Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.
Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...
Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.
A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.
WEDNESDAY, Dec. 17, 2025 (HealthDay News) — An over-the-counter supplement called lipoic acid might help slow the loss of gray matter in the brains of people with progressive multiple sclerosis (MS), ...
News-Medical.Net on MSN
Periodontal bacterial load associated with disease severity in multiple sclerosis
Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...
Fernando Mendoza prominently mentioned his mother in his Heisman Trophy acceptance speech. Here's what you should know about ...
Find out how combined chemical exposures and genetics may raise multiple sclerosis risk in new population research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback